NEW YORK, Oct. 13, 2016 -- Progyny, a leading digital healthcare company, today announced Karin Ajmani, president of healthcare services at Progyny, will present the abstract titled, “Employer Engagement and Education Increases Access to Care and eSET Utilization,” at the American Society for Reproductive (ASRM) Medicine 2016 Scientific Congress in Salt Lake City. The presentation will showcase results from companies that launched Progyny’s fertility benefits plan in January 2016. The abstract will be presented on Monday, October 17, 2016 at 11:15AM MT.
The presentation will highlight the significance of educating employers on best practices for assisted reproductive technology (ART) and clinical outcomes by providing a comprehensive benefit without restrictions on treatments or a defined dollar maximum. By providing employers with a Progyny SMART™ (Science and Member-driven Advanced Reproductive Technology) Cycle treatment plan which includes embryo assessment tools and promotion of elective Single Embryo Transfer (eSET), the company has been able to increase access to fertility care, increase pregnancy rates, and decrease multiples (twins or more) to four percent from a national average of 28 percent.
“Our goal is to eliminate the $1 billion annual healthcare costs related to high-risk maternity care, pre-term birth and NICU that stem from IVF multiples,” said Ajmani. “By giving employees access to the best technologies and utilization of eSET, we’re able to reduce the rate of twins and multiples which then reduces the overall maternity costs for the employer.”
“We are thrilled to present these results and the talented physicians in our network deserve a tremendous amount of recognition for this achievement as well,” added Gina Bartasi, CEO of Progyny. “Their partnership and leadership towards shifting the industry to single embryo transfer has been instrumental to our success.”
For more information about Progyny or to learn more the SMART cycle, visit booth #1009 at ASRM or visit www.progyny.com.
About Progyny:
Progyny is a leading digital healthcare company combining data, science and technology to provide the first end-to-end, proactive fertility solution for both large, self-insured employers and today’s informed consumer. Progyny’s SMART™ Cycle plan design comprises best-in-class research and clinical solutions, including its proprietary Eeva™ technology, to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. Progyny is privately held and is headquartered in New York, NY, with operations in San Francisco and Menlo Park, CA. Please visit www.progyny.com.
Media Contact: Selena Yang [email protected] Phone: 646-768-9719


Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Italy Fines Apple €98.6 Million Over App Store Dominance
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 



